Enterprise League logo
Innocrin Pharmaceuticals, Inc. Logo

Innocrin Pharmaceuticals, Inc.

Durham, United States (US) · Health and Medical

Do your work at Innocrin Pharmaceuticals, Inc.?

Claim this profile to manage your company.

Verified by Enterprise League

Data quality

Complete · Accuracy

Last verified

May 2026

Overview

Innocrin Pharmaceuticals is a US-based, clinical-stage pharmaceutical company specializing in the development of innovative oral CYP17 lyase inhibitors.

We are focused on addressing the critical needs of patients with castration-resistant prostate cancer (CRPC), a challenging and often aggressive form of the disease. Our lead product candidate targets this specific patient population, offering a potentially ‘best-in-class’ treatment option.

Innocrin’s research and development efforts extend to exploring the potential application of these inhibitors in other hormonally-driven conditions, including breast cancer, endometriosis, and congenital adrenal hyperlplasia. We are dedicated to advancing precision medicine through targeted therapies.

Founded in 2014, Innocrin Pharmaceuticals is committed to bringing transformative medicines to patients worldwide.

Most teams do this before shortlisting


Contact Details

info@innocrinpharma.com

Durham, United States (US)

Founded

2014

Company Type

Public Limited Company

Employees

2-10

Keywords

You're invisible in searches for:

Add keywords that describe your company, services, or market to improve your visibility in search results.

Companies teams usually look at after Innocrin Pharmaceuticals, Inc.

Comparing a few options usually leads to better decisions






  • Save companies to compare later. Useful when sharing options with your team

This is how your company profile looks to others.